We are in a major daily demand zone here, I will be looking for prices to bounce off of these levels with substantial volume and will hold some long calls. Thank you for partaking of my analysis.
Its right at the support line and could rally towards 160. It must stay above 95, otherwise its going further down. Its tech analysis and not any advice to buy/sell.
This is a Technical Analysis on Moderna (MRNA) on the 1 Week Timeframe. Current price action shows that we are currently in the process of breaking a MAJOR SUPPORT Zone. We held critical SUPPORT multiple times ABOVE the $115.00 level, for a span of about 26 months. Expressed by the GREEN circles. But notice we havent been able to successfully rally and stay...
Hello everyone Josh here again. I’m sure by now you’ve already heard mumblings of Covid’s imminent return. We are seeing everything from colleges to hospitals start to implement Covid policies. The news cycle is starting to warn of a dangerous flu season/Covid return. Governments around the world are now updating their Covid policies and sleepy Joe’s White House...
NVAX could be forming a large Weekly Inverse Head & Shoulder. If this pattern is to break out, it likely means we have new Covid strains and potential lockdowns.
BNTX a Germany company in the biotechnology and vaccine sectors out of Europe and Germany is looking good on the 2H chart here with a volume profile and an intermediate term VWAP overlaid. Price bounced off the bottom of the high volume area of the volume profile and looks to be ready for a reversion to the mean and even a sling-short move. The target here is...
MRNA is a medical technology company. It is in the vaccine sector and competes ( well) with NVAX and PFE among others. Earnings are upcoming on 8/3 in about a week. On the 30 minute chart it appears to be in a descending wedge pattern which is typically a bottoming with a breakout over and beyond the descending trendline. The relative trend indicator shows...
Discussing a potential capital rotation trade. We analyze Tesla, Amazon, Pfizer, Moderna, Hershey, and others to get a sense of what is going on.
Hello Folks, We can see Falling Wedge pattern clearly at MRNA with RSI positive divergence. I consider it important that this image is formed at a significant level of horizontal support. As a condition to enter the position, it would be reasonable to wait for the formation of a new high.
NVAX has had significant down trending over a wide range of time. On the 4H chart it seems to be pivoting from a swing bottom 3-4 days ago. This is accompanied by a cross of the MACD lines under the histogram on that indicator and a flip of volatility on the relative volatility indicator. NVAX has been subject to significant short selling. Price is presently...
This strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price...
I plan a short trade ( NASDAQ:MRNA ) at 144.41. The entry is just before the resistance zone at ~145.50 which is also confirmed by the Fibonacci 0.5 level. At 146.69 is the stop loss placed so that there is enough space to breathe. The take profit is very conservatively placed at a risk-reward ratio of 1:1.
MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into earnings tomorrow. MRNA needs to show something good otherwise it will break through the demand zone and keep going down. This is a risky earnings play betting that...
VAXX is a speculative penny biotechnology NASDAQ stock with high volatility. On the 2H chart, it is currently trending up from a swing low on April 25 with earnings to be reported Monday 5/8. May's relative volume compared with that of April is about 2-3X higher. To confirm the bullish bias, VAXX is currently trading above its intermediate-term POC line on...
NVAX is fundamentally weak with a shallow pipeline and no products currenly marketed to fund earnings and so research. On the 15 minute chart , NVAX is seen near to its demand zone as shown by the Luxalgo indicator. In the meanwhile, the RSI indicator shows considerable recent strength which is decreased today. So the question is whether NVAX can dead...
MRNA has been in a bearish trend from quite a while but now it has started to move back up Its following a very good resistance trend retest . The recent drop was due to bad news but it should be back on track soon According to FIB after crossing 176 the bullish reversal will be confirmed Entry @ 176 SL 170 TP after 202+
MRNA is not looking too good. What we can see is a weekly bearish engulfing candle after clear rejection from the upsloping resistance line. Rejection was nasty therefore we're seeing instant follow through. You can short it now with a final target at the support which is the entry for longs too. At the support, flip bullish and take a long position. The target...
$MRNA has bottomed recently, and has been trending logically in the daily timeframe, we have a 2nd signal forming here, continuing the uptrend that kicked off on March 13th. Upside can be substantial given broad market action, so I suggest to get involved with the stock (and likely also $PFE soon) here. Best of luck! Cheers, Ivan Labrie.